STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...
GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights over traditional panel testing. The company achieved a significant turnaround, becoming cash flow ...
More than four years after the COVID-19 pandemic caused the world to come to a standstill, lessons in pandemic response are still being learned. What we know: the global pandemic disproportionately ...
Rebecca Munoz said biomarker testing made a huge impact on her cancer journey. Now she's advocating for others to get the same option. "It was life-changing, obviously, to say the least," Munoz said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback